시장보고서
상품코드
1575010

임플란트 주위염 치료 시장 : 제품 유형별, 치료 유형별, 작용기서별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Peri-Implantitis Treatment Market, By Product Type, By Treatment Type, By Mechanism of Action, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 260 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

임플란트 주위염 치료 시장 규모는 2023년 24억 8,043만 달러로 2024년부터 2032년까지 CAGR 8.90%로 확대될 것으로 예상됩니다.

임플란트 주위염 치료 시장 - 시장 역학

노인 인구의 증가로 임플란트 주위염 치료 시장 수요 증가

노년층은 임플란트 고장을 포함한 치과 합병증에 걸리기 쉽기 때문에 노인 인구의 증가는 임플란트 주위염 치료 시장에 대한 수요를 크게 증가시키고 있습니다. 세계보건기구(WHO)에 따르면, 2050년까지 60세 이상 세계 인구는 20억 명에 달할 것으로 예상되며, 이에 따라 효과적인 치과 치료 솔루션에 대한 수요가 증가하고 있습니다. 또한, 임플란트 주위염은 임플란트 환자의 10-20% 정도가 앓고 있다는 연구 결과도 있어, 임플란트 주변염에 대한 집중적인 치료의 필요성이 강조되고 있습니다. 미국 치주과학회(American Academy of Periodontology)와 같은 단체의 노력은 예방 및 치료 옵션에 대한 의료 전문가 교육에 중점을 두고 있으며, 이는 시장 성장을 더욱 촉진하고 있습니다. 임플란트 주위염 치료 분야는 인식의 향상과 첨단 치료법의 채택으로 고령화 인구의 진화하는 요구에 부응할 수 있는 역량을 갖추고 있으며, 인구 추세와 의료 혁신의 중요한 교차점을 강조하고 있습니다.

임플란트 주위염 치료 시장 - 주요 인사이트

당사의 연구 분석가들의 분석에 따르면, 세계 시장은 예측 기간(2024-2032) 동안 매년 약 8.90%의 CAGR로 성장할 것으로 예상됩니다.

제품 유형별로는 항생제가 2023년 가장 큰 시장 점유율을 보일 것으로 예측됐습니다.

치료 유형별로는 비수술적 치료가 2023년 주요 치료 유형으로 나타났습니다.

작용기전별로는 2023년 국소투여가 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년 주요 수익원이었습니다.

임플란트 주위염 치료 시장 - 세분화 분석:

세계 임플란트 주위염 치료 시장은 제품 유형, 치료 유형, 작용 메커니즘, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 항생제, 방부제, 골이식편, 재생 재료 등 네 가지 범주로 나뉩니다. 항생제는 감염 관리에 효과적이기 때문에 우선적으로 사용되며, 그 다음으로 미생물 부하를 줄이는 데 도움이되는 방부제가 사용됩니다. 골이식편은 뼈의 완전성 회복에 중요한 역할을 하며, 재생 재료는 조직의 치유와 재생을 돕습니다.

시장은 치료 유형에 따라 비수술적 치료와 수술적 치료의 두 가지 범주로 나뉩니다. 비수술적 치료는 초기 단계의 최소침습적 효과에 우선순위를 두는 반면, 수술적 치료는 임플란트의 건강과 기능을 회복하기 위해 더 광범위한 개입이 필요한 진행성 질환에 필수적입니다.

임플란트 주위염 치료 시장 - 지리적 인사이트

임플란트 주위염 치료 시장은 지역별로 큰 차이를 보이지만, 북미는 의료 인프라가 잘 갖추어져 있고 임플란트 보급률이 높기 때문에 주요 지역으로 꼽힙니다. 미국 치과의사협회는 미국에서 약 300만 명이 임플란트 치료를 받고 있어 임플란트 주위염 치료의 필요성이 증가하고 있다고 지적했습니다. 독일, 영국 등의 국가에서는 임플란트 치료 결과를 개선하기 위해 첨단 치과 기술 및 연구 이니셔티브에 투자하고 있습니다. 아시아태평양에서는 급속한 도시화와 가처분 소득의 증가가 치과 임플란트 및 관련 치료에 대한 수요를 견인하고 있으며, 태국과 인도와 같은 국가에서는 치과 관광이 눈에 띄게 증가하고 있습니다. 한편, 중동 및 아프리카에서는 의료 인프라 개선을 위한 노력으로 치과 치료에 대한 인식과 접근성이 점차 향상되고 있습니다. 세계 협력과 연구가 확대됨에 따라 임플란트 주위염의 치료 환경은 진화하고, 각 지역이 직면한 고유한 문제를 해결하면서 전 세계적으로 더 나은 구강 위생 관행을 촉진할 수 있을 것으로 보입니다.

임플란트 주위염 치료 시장 - 경쟁 상황:

임플란트 주위염 치료 시장의 경쟁 구도에서는 Zimmer Biomet, Dentsply Sirona 등 혁신적인 치료 솔루션을 선도하고 있는 주요 기업들이 주도하는 북미가 지배적인 지역으로 부상하고 있습니다. 미국 치주과학회(American Academy of Periodontology)는 치과 임플란트 환자의 약 10-20%가 임플란트 주위염을 경험하는 것으로 보고하고 있으며, 이는 첨단 치료의 성장에 박차를 가하고 있습니다. 유럽에서는 스트라우만(Straumann), 바이오호라이즌스(BioHorizons) 등 주요 기업들이 치료 효과를 높이기 위한 엄격한 임상연구를 바탕으로 선도적인 역할을 하고 있습니다. 아시아태평양에서는 구강 건강에 대한 인식 증가와 치과 임플란트 보급이 시장 성장을 촉진하고 있으며, Osstem Implant와 같은 지역 기업들이 시장을 주도하고 있습니다. 중동 및 아프리카에서는 치과 의료에 대한 투자가 증가하고 있으며, 양질의 임플란트 주위염 치료에 대한 접근성 향상에 중점을 둔 지역적 노력이 진행되고 있습니다. 전반적인 경쟁 환경은 기존 기업과 신생 기업이 혼재되어 있으며, 이들 모두 효과적인 임플란트 주위염 관리 솔루션에 대한 세계 수요 증가에 대응하기 위해 노력하고 있습니다.

목차

제1장 임플란트 주위염 치료 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 임플란트 주위염 치료의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 임플란트 주위염 치료 산업 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 임플란트 주위염 치료 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 임플란트 주위염 치료 시장 상황

  • 임플란트 주위염 치료 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 임플란트 주위염 치료 시장 - 제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 항생제
    • 방부제
    • 골이식
    • 재생 재료

제8장 임플란트 주위염 치료 시장 - 치료 유형별

  • 개요
    • 치료 유형별 부문 점유율 분석
    • 비외과적 치료
    • 외과적 치료

제9장 임플란트 주위염 치료 시장 - 작용기서별

  • 개요
    • 작용기서별 부문 점유율 분석
    • 국소적 투여
    • 전신 투여

제10장 임플란트 주위염 치료 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 치과의원
    • 병원
    • 연구기관

제11장 임플란트 주위염 치료 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 임플란트 주위염 치료 업계

  • 경쟁 대시보드
  • 기업 개요
    • Bicon, LLC
    • BioHorizons IPH, Inc.
    • Camlog Biotechnologies AG
    • Corus Medical, Inc.
    • Dentium Co., Ltd.
    • Dentsply Sirona Inc.
    • Henry Schein, Inc.
    • Hiossen, Inc.
    • Implant Direct Sybron International
    • Keystone Dental, Inc.
    • Megagen Implant Co., Ltd.
    • Nobel Biocare Services AG
    • Osstem Implant Co., Ltd.
    • Straumann Holding AG
    • TBR Implants
    • Zimmer Biomet Holdings, Inc.
    • Others

제13장 애널리스트의 전방위 전망

ksm 24.11.05

REPORT HIGHLIGHT

Peri-Implantitis Treatment Market size was valued at USD 2,480.43 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The peri-implantitis treatment market focuses on addressing inflammation and bone loss around dental implants, affecting a significant portion of the population, with studies indicating that up to 30% of implant patients experience peri-implantitis at some point. Factors such as the increasing prevalence of dental implants, the rising geriatric population, and advancements in dental technologies are propelling market growth. However, challenges such as high treatment costs and limited patient awareness may restrain market expansion. Opportunities lie in the development of innovative treatment modalities, such as laser therapy and biomaterials for enhanced healing. Additionally, educational initiatives aimed at dental professionals and patients can further drive awareness and treatment adoption, ensuring better outcomes for those affected by this condition. Organizations like the American Academy of Periodontology emphasize the importance of peri-implant health, further supporting the need for effective treatment solutions.

Peri-Implantitis Treatment Market- Market Dynamics

Increasing Geriatric Population Fuels Demand in the Peri-Implantitis Treatment Market

The rising geriatric population is significantly boosting demand in the peri-implantitis treatment market, as older adults are more prone to dental complications, including implant failures. According to the World Health Organization, the global population aged 60 and older is projected to reach 2 billion by 2050, leading to a heightened need for effective dental care solutions. Moreover, studies have shown that peri-implantitis affects nearly 10-20% of implant patients, underscoring the necessity for targeted treatments. Initiatives from organizations like the American Academy of Periodontology are focusing on educating healthcare professionals about prevention and treatment options, further driving market growth. With increasing awareness and the adoption of advanced therapeutic methods, the peri-implantitis treatment sector is well-positioned to meet the evolving needs of an aging population, highlighting the critical intersection of demographic trends and healthcare innovation.

Peri-Implantitis Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on product type segmentation, antibiotics were predicted to show maximum market share in the year 2023

Based on Treatment Type segmentation, Non-Surgical Treatments was the leading type in 2023

Based on Mechanism of Action segmentation, Localized Delivery was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Peri-Implantitis Treatment Market- Segmentation Analysis:

The Global Peri-Implantitis Treatment Market is segmented on the basis of Product Type, Treatment Type, Mechanism of Action, End-User, and Region.

The market is divided into four categories based on product type: Antibiotics, Antiseptics, Bone Grafts, and Regenerative Materials. Antibiotics are prioritized due to their effectiveness in managing infections, followed by antiseptics that help in reducing microbial load. Bone grafts play a crucial role in restoring bone integrity, while regenerative materials support tissue healing and regeneration.

The market is divided into two categories based on Treatment Type: Non-Surgical Treatments and Surgical Treatments. Non-surgical treatments are prioritized for their minimally invasive nature and effectiveness in early stages, while surgical treatments are essential for advanced cases requiring more extensive intervention to restore implant health and function.

Peri-Implantitis Treatment Market- Geographical Insights

The peri-implantitis treatment market exhibits significant regional variations, with North America emerging as a leading region due to its advanced healthcare infrastructure and high adoption rates of dental implants. The American Dental Association highlights that nearly 3 million people in the U.S. have dental implants, increasing the need for peri-implantitis treatments. Europe follows closely, where countries like Germany and the UK invest in advanced dental technologies and research initiatives aimed at improving implant outcomes. In Asia-Pacific, rapid urbanization and rising disposable incomes are driving the demand for dental implants and associated treatments, with a notable increase in dental tourism in countries like Thailand and India. Meanwhile, the Middle East and Africa are gradually increasing awareness and accessibility to dental care, as initiatives focus on improving healthcare infrastructure. As global collaborations and research expand, the treatment landscape for peri-implantitis is set to evolve, addressing the unique challenges faced in different regions while promoting better oral health practices worldwide.

Peri-Implantitis Treatment Market- Competitive Landscape:

In the competitive landscape of the peri-implantitis treatment market, North America stands out as a dominant region, driven by key players such as Zimmer Biomet and Dentsply Sirona, who are at the forefront of innovative treatment solutions. The American Academy of Periodontology has reported that approximately 10% to 20% of dental implant patients experience peri-implantitis, spurring growth in advanced therapies. Europe follows closely, with companies like Straumann and BioHorizons leading the charge, supported by rigorous clinical studies to enhance treatment efficacy. In Asia-Pacific, growing awareness of oral health and increasing dental implant adoption are fostering market growth, with regional players like Osstem Implant gaining traction. The Middle East and Africa are witnessing a rise in dental healthcare investments, with local initiatives focusing on improving access to quality peri-implantitis treatments. Overall, the competitive landscape is characterized by a mix of established players and emerging companies, all striving to address the increasing demand for effective peri-implantitis management solutions globally.

Recent Developments:

In November 2023, UCLA researchers developed a groundbreaking UV light technology to combat peri-implantitis, significantly enhancing osseointegration and reducing complications. The one-minute UV treatment removes hydrocarbons from titanium implants, promoting faster healing and limiting bacterial invasion, aiming to eradicate peri-implantitis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Bicon, LLC
  • BioHorizons IPH, Inc.
  • Camlog Biotechnologies AG
  • Corus Medical, Inc.
  • Dentium Co., Ltd.
  • Dentsply Sirona Inc.
  • Henry Schein, Inc.
  • Hiossen, Inc.
  • Implant Direct Sybron International
  • Keystone Dental, Inc.
  • Megagen Implant Co., Ltd.
  • Nobel Biocare Services AG
  • Osstem Implant Co., Ltd.
  • Straumann Holding AG
  • TBR Implants
  • Zimmer Biomet Holdings, Inc.
  • Others

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Antibiotics
  • Antiseptics
  • Bone Grafts
  • Regenerative Materials

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Non-Surgical Treatments
  • Surgical Treatments

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY MECHANISM OF ACTION- MARKET ANALYSIS, 2019 - 2032

  • Localized Delivery
  • Systemic Delivery

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Dental Clinics
  • Hospitals
  • Research Laboratories

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Peri-Implantitis Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Peri-Implantitis Treatment Market Snippet by Product Type
    • 2.1.2. Peri-Implantitis Treatment Market Snippet by Treatment Type
    • 2.1.3. Peri-Implantitis Treatment Market Snippet by Mechanism of Action
    • 2.1.4. Peri-Implantitis Treatment Market Snippet by End-User
    • 2.1.5. Peri-Implantitis Treatment Market Snippet by Country
    • 2.1.6. Peri-Implantitis Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Peri-Implantitis Treatment Key Market Trends

  • 3.1. Peri-Implantitis Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Peri-Implantitis Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Peri-Implantitis Treatment Market Opportunities
  • 3.4. Peri-Implantitis Treatment Market Future Trends

4. Peri-Implantitis Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Peri-Implantitis Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Peri-Implantitis Treatment Market Landscape

  • 6.1. Peri-Implantitis Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Peri-Implantitis Treatment Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Antibiotics
    • 7.1.3. Antiseptics
    • 7.1.4. Bone Grafts
    • 7.1.5. Regenerative Materials

8. Peri-Implantitis Treatment Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2023 & 2032 (%)
    • 8.1.2. Non-Surgical Treatments
    • 8.1.3. Surgical Treatments

9. Peri-Implantitis Treatment Market - By Mechanism of Action

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Mechanism of Action, 2023 & 2032 (%)
    • 9.1.2. Localized Delivery
    • 9.1.3. Systemic Delivery

10. Peri-Implantitis Treatment Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Dental Clinics
    • 10.1.3. Hospitals
    • 10.1.4. Research Laboratories

11. Peri-Implantitis Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Peri-Implantitis Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Peri-Implantitis Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Peri-Implantitis Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Peri-Implantitis Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Peri-Implantitis Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Peri-Implantitis Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Bicon, LLC
    • 12.2.2. BioHorizons IPH, Inc.
    • 12.2.3. Camlog Biotechnologies AG
    • 12.2.4. Corus Medical, Inc.
    • 12.2.5. Dentium Co., Ltd.
    • 12.2.6. Dentsply Sirona Inc.
    • 12.2.7. Henry Schein, Inc.
    • 12.2.8. Hiossen, Inc.
    • 12.2.9. Implant Direct Sybron International
    • 12.2.10. Keystone Dental, Inc.
    • 12.2.11. Megagen Implant Co., Ltd.
    • 12.2.12. Nobel Biocare Services AG
    • 12.2.13. Osstem Implant Co., Ltd.
    • 12.2.14. Straumann Holding AG
    • 12.2.15. TBR Implants
    • 12.2.16. Zimmer Biomet Holdings, Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제